Is Semaglutide safe for weight loss in multiple myeloma?

Question

Hello doctor,

I have been researching Semaglutide, particularly compounded versions, for weight management and blood sugar control. Given the weight gain I have experienced during my multiple myeloma treatment, I am considering this option. I understand semaglutide is approved for type 2 diabetes and obesity, but I am concerned about its safety in the context of my ongoing cancer therapy.

Could you advise on the following:

Is Semaglutide safe to use alongside my current multiple myeloma medications? Are there potential interactions or effects on my immune system and blood counts?
Are compounded versions of Semaglutide as reliable and safe as the brand-name options?
What side effects should I be aware of, such as nausea or pancreatitis, that might complicate my cancer treatment?
Could Semaglutide help improve my energy levels and metabolic health, especially in managing side effects from steroids or chemotherapy?
Would I need clearance from my oncologist before starting Semaglutide, and would regular monitoring be required during its use?

I appreciate your guidance on whether Semaglutide is a suitable option for me. Please help.

Thank you.

Answer 1

Hi,

Welcome to icliniq.com.

I understand your concern.

Thank you for reaching out with your questions regarding the use of Semaglutide during your treatment for multiple myeloma (blood cancer in plasma cells within the bone marrow). It is commendable that you are proactively seeking information to manage your health.

Safety and interactions of Semaglutide:

Semaglutide has shown effectiveness in weight management and blood sugar control. However, it is crucial to consider potential interactions with your current cancer treatments. Specifically, medications like Bortezomib, commonly used in multiple myeloma therapy, may interact with Semaglutide, potentially affecting blood glucose levels. Therefore, it is essential to consult your oncologist before initiating Semaglutide to ensure it is safe in conjunction with your current regimen.

2. Compounded vs. brand-name Semaglutide:

While compounded Semaglutide formulations are available, they may not undergo the same rigorous testing and quality control as brand-name versions. This could lead to variations in potency and efficacy. Opting for FDA (Food and Drug Administration)-approved brand-name medications is generally recommended to ensure consistency and safety.

3. Potential risks:

Common side effects of Semaglutide include nausea, vomiting, and gastrointestinal discomfort. These symptoms could overlap with or increase the side effects from cancer treatments, potentially impacting your overall well-being. Additionally, there is a noted risk of pancreatitis (inflammation of the pancreas), which requires careful monitoring.

4. Clearance:

Before starting Semaglutide, obtaining clearance from your oncology team is important.

5. Monitoring:

Regular monitoring of your blood counts, glucose levels, and overall health status would be necessary to promptly identify and manage any adverse effects.

If you would like to discuss this further or have additional questions, please do not hesitate to schedule a consultation. I am here to support you in making informed decisions about your health.

I hope this helps.

Thank you.